SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-001781
Filing Date
2018-03-16
Accepted
2018-03-16 17:24:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2234903z424b5.htm 424B5 224951
2 G124138.JPG g124138.jpg GRAPHIC 14802
3 G232259.JPG g232259.jpg GRAPHIC 20548
  Complete submission text file 0001047469-18-001781.txt   274855
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-219794 | Film No.: 18696713
SIC: 2834 Pharmaceutical Preparations